CLINICAL_TRIALS
trial_result
· 2021-11-04
Clinical Trial Update: A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients [Phase 3]
Summary
Phase 3 trial evaluating three drugs plus zidovudine for prevention of infections in HIV-infected patients has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Pneumonia, Pneumocystis Carinii, HIV Infections | Phase 3 | Status: COMPLETED